Aims: Characterize different sized ceria-engineered nanomaterial (ENM) distribution in, and
clearance from, blood (compared to the cerium ion) following intravenous infusion. Materials …

A 30 nm ceria was previously shown to be primarily cleared from systemic circulation into
mononuclear phagocyte system organs after its intravenous (IV) administration, where it …

The aims were to determine the biodistribution, translocation, and persistence of nanoceria
in the brain and selected peripheral organs. Nanoceria is being studied as an anti-oxidant …

Purpose Ceria engineered nanomaterials (ENMs) have current commercial applications and
both neuroprotective and toxic effects. Our hypothesis is that ceria ENMs can associate with …

Background Cerium dioxide nanoparticles (nanoceria) are increasingly being used in a
variety of products as catalysts, coatings, and polishing agents. Furthermore, their …

The objective was to characterize the biodistribution of nanoscale ceria from blood and its
effects on oxidative stress endpoints. A commercial 5% crystalline ceria dispersion in water …

Nanoparticle (NP) pharmacokinetics significantly differ from traditional small molecule
principles. From this emerges the need to create new tools and concepts to harness their full …

Cerium oxide nanoparticles, nanoceria, have been proposed as drug delivery devices and
therapeutic tools also for neurological diseases due to their antioxidant properties and …

Cerium oxide nanoparticles (nanoceria) are widely reported to be cytocompatible and
modulate intracellular reactive oxygen species (ROS) in a range of different cell types. In this …

Nanoceria is used as a catalyst in diesel fuel, as an abrasive in printed circuit manufacture,
and is being pursued as an antioxidant therapeutic. Our objective is to extend previous …